The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Hepatobiliary transporters and drug‐induced cholestasis†
Abstract
Drug-induced liver injury is an important clinical problem with significant morbidity and mortality. Whereas for most hepatocellular forms of drug-induced hepatic injury the underlying pathophysiological mechanism is poorly understood, there is increasing evidence that cholestatic forms of drug-induced liver damage result from a drug- or metabolite-mediated inhibition of hepatobiliary transporter systems. In addition to their key role in determining hepatic drug exposure and clearance, the coordinated action of these transport systems is essential for bile formation and the biliary secretion of cholephilic compounds and xenobiotics. Any drug-mediated functional disturbance of these processes can lead to an intracellular accumulation of potentially harmful bile constituents and result in the development of cholestatic liver cell damage. In addition to direct drug-mediated inhibition of hepatocellular transport, function of these transporters can be altered by pre-existing hepatic disease and genetic factors, which contribute to the development of drug-induced cholestasis in susceptible individuals. This review summarizes current knowledge about the function of hepatobiliary uptake and efflux systems and discusses factors that might predispose to drug-induced cholestasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmöller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3473 · Cited by 2,365
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
Criteria of drug-induced liver disorders
(1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90124-a · Cited by 1,106
Kim, R. B., Fromm, M. F., Wandel, C., Leake, B., Wood, A. J., Roden, D. M., & Wilkinson, G. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1269 · Cited by 1,054
Hagenbuch, B., & Meier, P. J. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1168-y · Cited by 1,019
Self-citationIdentification of functionally variant MDR1 alleles among European Americans and African Americans
Kim, R. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117412 · Cited by 1,009
Bile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999
Strautnieks, S. S., Bull, L. N., Knisely, A. S., Kocoshis, S. A., Dahl, N., Arnell, H., Sokal, E., Dahan, K., Childs, S., Ling, V., et al. (1998) · Nature Genetics · doi:10.1038/3034 · Cited by 995
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H.-P., von Richter, O., Zundler, J., & Kroemer, H. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6663 · Cited by 917
Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916
Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin
Geick, A., Eichelbaum, M., & Burk, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010173200 · Cited by 848
Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J., & Suchy, F. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011610200 · Cited by 801
Enterohepatic bile salt transporters in normal physiology and liver disease
Kullak-ublick, G. A., Stieger, B., & Meier, P. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.06.005 · Cited by 658
Self-citationFellay, J., Marzolini, C., Meaden, E. R., Back, D. J., Buclin, T., Chave, J.-P., Decosterd, L. A., Furrer, H., Opravil, M., Pantaleo, G., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07276-8 · Cited by 658
Tirona, R. G., Leake, B. F., Merino, G., & Kim, R. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103792200 · Cited by 626
Importance of P-glycoprotein at blood–tissue barriers
Fromm, M. F. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.002 · Cited by 592
Meier, P. J., & Stieger, B. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.082201.100300 · Cited by 586
Self-citationSt John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
Dürr, D. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.112240 · Cited by 584
Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G. A., & Meier, P. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70224-1 · Cited by 582
Self-citationThe SLC22 drug transporter family
Koepsell, H., & Endou, H. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1089-9 · Cited by 525
Jacquemin, E., Bernard, O., Hadchouel, M., Cresteil, D., De Vree, J. M. L., Paul, M., Elferink, R. P. J. O., Bosma, P. J., Sokal, E. M., Sturm, E., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.23984 · Cited by 523
Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin
Fischer, W. J., Altheimer, S., Cattori, V., Meier, P. J., Dietrich, D. R., & Hagenbuch, B. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.08.012 · Cited by 520
Self-citationNishizato, Y. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00060-2 · Cited by 511
Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
Denson, L. A., Sturm, E., Echevarria, W., Zimmerman, T. L., Makishima, M., Mangelsdorf, D. J., & Karpen, S. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.25503 · Cited by 460
Interrelationship Between Substrates and Inhibitors of Human CYP3A and P-Glycoprotein
Kirn, R. B., Wandel, C., Leake, B., Cvetkovic, M., Fromm, M. F., Dempsey, P. J., Roden, M. M., Belas, F., Chaudhary, A. K., Roden, D. M., et al. (1999) · Pharmaceutical Research · doi:10.1023/a:1018877803319 · Cited by 454
Niemi, M., Schaeffeler, E., Lang, T., Fromm, M. F., Neuvonen, M., Kyrklund, C., Backman, J. T., Kerb, R., Schwab, M., Neuvonen, P. J., et al. (2004) · Pharmacogenetics · doi:10.1097/01.fpc.0000114750.08559.32 · Cited by 418
Hitzl, M., Drescher, S., van der Kuip, H., Schäffeler, E., Fischer, J., Schwab, M., Eichelbaum, M., & Fromm, M. F. (2001) · Pharmacogenetics · doi:10.1097/00008571-200106000-00003 · Cited by 374
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver
Vavricka, S. R., Van Montfoort, J., Ha, H. R., Meier, P. J., & Fattinger, K. (2002) · Hepatology · doi:10.1053/jhep.2002.34133 · Cited by 373
Self-citationHeterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy
Jacquemin, E., Cresteil, D., Manouvrier, S., Boute, O., & Hadchouel, M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)77221-4 · Cited by 367
Zollner, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22646 · Cited by 362
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
van Mil, S. W. C., van der Woerd, W. L., van der Brugge, G., Sturm, E., Jansen, P. L. M., Bull, L. N., van den Berg, I. E. T., Berger, R., Houwen, R. H. J., & Klomp, L. W. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.065 · Cited by 345
ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics
Suzuki, M., Suzuki, H., Sugimoto, Y., & Sugiyama, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212399200 · Cited by 341
Lang, C., Meier, Y., Stieger, B., Beuers, U., Lang, T., Kerb, R., Kullak-Ublick, G. A., Meier, P. J., & Pauli-Magnus, C. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000230418.28091.76 · Cited by 339
Self-citationByrne, J. A., Strautnieks, S. S., Mieli–Vergani, G., Higgins, C. F., Linton, K. J., & Thompson, R. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36591 · Cited by 337
Ballatori, N., Christian, W. V., Lee, J. Y., Dawson, P. A., Soroka, C. J., Boyer, J. L., Madejczyk, M. S., & Li, N. (2005) · Hepatology · doi:10.1002/hep.20961 · Cited by 335
Schuetz, E. G., Strom, S., Yasuda, K., Lecureur, V., Assem, M., Brimer, C., Lamba, J., Kim, R. B., Ramachandran, V., Komoroski, B. J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106340200 · Cited by 334
Yu, L., York, J., von Bergmann, K., Lutjohann, D., Cohen, J. C., & Hobbs, H. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301311200 · Cited by 323
Nozawa, T., Minami, H., Sugiura, S., Tsuji, A., & Tamai, I. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001909 · Cited by 316
Molecular Characterization and Inhibition of Amanitin Uptake into Human Hepatocytes
Letschert, K., Faulstich, H., Keller, D., & Keppler, D. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj141 · Cited by 298
Funk, C., Ponelle, C., Scheuermann, G., & Pantze, M. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12255-9 · Cited by 296
Evidence for inverse effects of OATP-C (SLC21A6) *5 and *1b haplotypes on pravastatin kinetics
Mwinyi, J. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.12.016 · Cited by 293
Plass, J. R. M., Mol, O., Heegsma, J., Geuken, M., Faber, K. N., Jansen, P. L. M., & Müller, M. (2002) · Hepatology · doi:10.1053/jhep.2002.31724 · Cited by 290
Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis
Zollner, G., Fickert, P., Silbert, D., Fuchsbichler, A., Marschall, H.-U., Zatloukal, K., Denk, H., & Trauner, M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00096-5 · Cited by 275
Pauli-Magnus, C., Lang, T., Meier, Y., Zodan-Marin, T., Jung, D., Breymann, C., Zimmermann, R., Kenngott, S., Beuers, U., Reichel, C., et al. (2004) · Pharmacogenetics · doi:10.1097/00008571-200402000-00003 · Cited by 273
Self-citationFunctional expression of the canalicular bile salt export pump of human liver
Noé, J., Stieger, B., & Meier, P. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36587 · Cited by 267
Self-citationDrug–Induced Liver Injury: Mechanisms and Test Systems
Bissell, M. D., Gores, G. J., Laskin, D. L., & Hoofnagle, J. H. (2001) · Hepatology · doi:10.1053/jhep.2001.23505 · Cited by 267
The sodium bile salt cotransport family SLC10
Hagenbuch, B., & Dawson, P. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1130-z · Cited by 266
Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism
Eloranta, J. J., & Kullak-Ublick, G. A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.019 · Cited by 260
Involvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin
Hirano, M., Maeda, K., Matsushima, S., Nozaki, Y., Kusuhara, H., & Sugiyama, Y. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014019 · Cited by 256
Smith, A. J., van Helvoort, A., van Meer, G., Szabó, K., Welker, E., Szakács, G., Váradi, A., Sarkadi, B., & Borst, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909002199 · Cited by 252
MDR1 gene polymorphisms and disposition of the P‐glycoprotein substrate fexofenadine
Drescher, S., Schaeffeler, E., Hitzl, M., Hofmann, U., Schwab, M., Brinkmann, U., Eichelbaum, M., & Fromm, M. F. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01591.x · Cited by 249
Farnesoid X Receptor Activates Transcription of the Phospholipid Pump MDR3
Huang, L., Zhao, A., Lew, J.-L., Zhang, T., Hrywna, Y., Thompson, J. R., de Pedro, N., Royo, I., Blevins, R. A., Peláez, F., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308321200 · Cited by 248
Bile acid-induced negative feedback regulation of the human ileal bile acid transporter
Neimark, E., Chen, F., Li, X., & Shneider, B. L. (2004) · Hepatology · doi:10.1002/hep.20295 · Cited by 234
Single nucleotide polymorphisms modify the transporter activity of ABCG2
Morisaki, K., Robey, R. W., Özvegy-Laczka, C., Honjo, Y., Polgar, O., Steadman, K., Sarkadi, B., & Bates, S. E. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0931-x · Cited by 230
Meier, Y., Pauli-Magnus, C., Zanger, U. M., Klein, K., Schaeffeler, E., Nussler, A. K., Nussler, N., Eichelbaum, M., Meier, P. J., & Stieger, B. (2006) · Hepatology · doi:10.1002/hep.21214 · Cited by 219
Self-citationChitturi, S., & George, J. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30102 · Cited by 216
Homolya, L., Váradi, A., & Sarkadi, B. (2003) · BioFactors · doi:10.1002/biof.5520170111 · Cited by 208
Hepatocyte Nuclear Factor 1α: A Key Mediator of the Effect of Bile Acids on Gene Expression
Jung, D., & Kullak-Ublick, G. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50100 · Cited by 194
Jamroziak, K., Młynarski, W., Balcerczak, E., Mistygacz, M., Treliǹska, J., Mirowski, M., Bodalski, J., & Robak, T. (2004) · European Journal of Haematology · doi:10.1111/j.1600-0609.2004.00228.x · Cited by 194
Pauli-Magnus, C., Kerb, R., Fattinger, K., Lang, T., Anwald, B., Kullak-Ublick, G. A., Beuers, U., & Meier, P. J. (2004) · Hepatology · doi:10.1002/hep.20159 · Cited by 181
Self-citationEnterohepatic transport of bile salts and genetics of cholestasis
Pauli-Magnus, C., Stieger, B., Meier, Y., Kullak-Ublick, G. A., & Meier, P. J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.017 · Cited by 175
Self-citationVanishing bile duct syndrome in drug-induced liver disease
Desmet, V. J. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)82330-6 · Cited by 174
Jung, D., Podvinec, M., Meyer, U. A., Mangelsdorf, D. J., Fried, M., Meier, P. J., & Kullak–Ublick, G. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.33583 · Cited by 170
Self-citationJung, D., Hagenbuch, B., Gresh, L., Pontoglio, M., Meier, P. J., & Kullak-Ublick, G. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103988200 · Cited by 170
Self-citationKurz, A. K., Graf, D., Schmitt, M., Vom Dahl, S., & Häussinger, D. (2001) · Gastroenterology · doi:10.1053/gast.2001.26262 · Cited by 168
Noé, J., Kullak-Ublick, G. A., Jochum, W., Stieger, B., Kerb, R., Haberl, M., Müllhaupt, B., Meier, P. J., & Pauli‐Magnus, C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.020 · Cited by 143
Self-citationLazaridis, K. N., Tietz, P. S., Wu, T., Kip, S. N., Dawson, P. A., & LaRusso, N. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200325297 · Cited by 138
Misra, S., Ujházy, P., Gatmaitan, Z., Varticovski, L., & Arias, I. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26638 · Cited by 132
MRP2 and 3 in health and disease
Borst, P., Zelcer, N., & van de Wetering, K. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.05.051 · Cited by 107
Fehrenbach, T., Cui, Y., Faulstich, H., & KEPPLER, D. O. R. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0814-4 · Cited by 106
Rost, D., König, J., Weiß, G., Klar, E., Stremmel, W., & KEPPLER, D. O. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.28648 · Cited by 101
Misra, S., Ujházy, P., Varticovski, L., & Arias, I. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5814 · Cited by 101
Hepatobiliary complications of oral contraceptives
LINDBERG, M. C. (1992) · Journal of General Internal Medicine · doi:10.1007/bf02598014 · Cited by 94
Kajinami, K., Brousseau, M. E., Nartsupha, C., Ordovás, J. M., & Schaefer, E. J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300278-jlr200 · Cited by 92
Bolder, U., Trang, N. V., Hagey, L. R., Schteingart, C. D., Ton‐Nu, H., Cerré, C., Elferink, R. P. J. O., & Hofmann, A. F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70356-2 · Cited by 82
Wang, P., Wang, J. J., Xiao, Y., Murray, J. W., Novikoff, P. M., Angeletti, R. H., Orr, G. A., Lan, D., Silver, D. L., & Wolkoff, A. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503969200 · Cited by 82
MORPHOLOGIC SPECTRUM OF DRUG-INDUCED HEPATIC DISEASE
Ishak, K. G., & Zimmerman, H. J. (1995) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00227-2 · Cited by 81
Fouassier, L., Kinnman, N., Lefèvre, G., Lasnier, E., Rey, C., Poupon, R. Y., Elferink, R. P. J. O., & Housset, C. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00107-1 · Cited by 81
Role of the PI3K/PKB signaling pathway in cAMP-mediated translocation of rat liver Ntcp
Webster, C. R. L., & Anwer, M. S. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.6.g1165 · Cited by 81
Biliary lipids, water and cholesterol gallstones
van Erpecum, K. J. (2005) · Biology of the Cell · doi:10.1042/bc20040088 · Cited by 79
The mechanism of ABCG5/ABCG8 in biliary cholesterol secretion in mice
Kosters, A., Kunne, C., Looije, N., et al. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500511-jlr200 · Cited by 67
Leevy, C. B., Koneru, B., & Klein, K. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70193-8 · Cited by 55
Benedetti, A., Sario, A. D., Marucci, L., Svegliati‐Baroni, G., Schteingart, C. D., Ton-Nu, H.-T., & Hofmann, A. F. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.6.g1416 · Cited by 48
Genetic defenses against noncholesterol sterols
Klett, E. L., & Patel, S. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200308000-00001 · Cited by 35
FIC1: another bile salt carrier within the enterohepatic circulation?
Stieger, B. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00182-9 · Cited by 14
McIndoe, G. A., Kw, M., & Reddy, J. O. (1981) · PubMed · Cited by 11
Cited by
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
Dawson, P. A., Lan, T., & Rao, A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900012-jlr200 · Cited by 680
Guillouzo, A., Corlu, A., Aninat, C., Glaise, D., Morel, F., & Guguen-Guillouzo, C. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.12.003 · Cited by 675
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
Zhou, S.-F. (2008) · Xenobiotica · doi:10.1080/00498250701867889 · Cited by 599
Bile Acid Transporters: Structure, Function, Regulation and Pathophysiological Implications
Alrefai, W. A., & Gill, R. K. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9289-1 · Cited by 500
Metadata
- Authors
- Pauli‐Magnus, C., & Meier, P. J.
- Venue
- Hepatology
- Published
- 2006-10
- Volume
- 44
- Issue
- 4
- Pages
- 778-787
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2047527636
- Cited by
- 285
- References
- 87
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.